Cite
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator.
MLA
Lloyd, Michael S., et al. “Design and Rationale of the MODULAR ATP Global Clinical Trial: A Novel Intercommunicative Leadless Pacing System and the Subcutaneous Implantable Cardioverter-Defibrillator.” Heart Rhythm O2, vol. 4, no. 7, June 2023, pp. 448–56. EBSCOhost, https://doi.org/10.1016/j.hroo.2023.05.004.
APA
Lloyd, M. S., Brisben, A. J., Reddy, V. Y., Blomström-Lundqvist, C., Boersma, L. V. A., Bongiorni, M. G., Burke, M. C., Cantillon, D. J., Doshi, R., Friedman, P. A., Gras, D., Kutalek, S. P., Neuzil, P., Roberts, P. R., Wright, D. J., Appl, U., West, J., Carter, N., Stein, K. M., … Knops, R. E. (2023). Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm O2, 4(7), 448–456. https://doi.org/10.1016/j.hroo.2023.05.004
Chicago
Lloyd, Michael S, Amy J Brisben, Vivek Y Reddy, Carina Blomström-Lundqvist, Lucas V A Boersma, Maria Grazia Bongiorni, Martin C Burke, et al. 2023. “Design and Rationale of the MODULAR ATP Global Clinical Trial: A Novel Intercommunicative Leadless Pacing System and the Subcutaneous Implantable Cardioverter-Defibrillator.” Heart Rhythm O2 4 (7): 448–56. doi:10.1016/j.hroo.2023.05.004.